BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12634934)

  • 21. 2,3-Butanedione monoxime (BDM) decreases sarcoplasmic reticulum Ca content by stimulating Ca release in isolated rat ventricular myocytes.
    Adams W; Trafford AW; Eisner DA
    Pflugers Arch; 1998 Oct; 436(5):776-81. PubMed ID: 9716712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of sarcoplasmic reticulum Ca2+ release by 2,3-butanedione monoxime in crustacean muscle.
    Györke S; Dettbarn C; Palade P
    Pflugers Arch; 1993 Jun; 424(1):39-44. PubMed ID: 8351205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The myosin ATPase inhibitor 2,3-butanedione-2-monoxime (BDM) inhibits tip growth and cytokinesis in the fission yeast, Schizosaccharomyces pombe.
    May KM; Wheatley SP; Amin V; Hyams JS
    Cell Motil Cytoskeleton; 1998; 41(2):117-25. PubMed ID: 9786087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of acto-myosin contractility in skeletal muscle myoblasts uncouples growth arrest from differentiation.
    Dhawan J; Helfman DM
    J Cell Sci; 2004 Aug; 117(Pt 17):3735-48. PubMed ID: 15252113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Non-specific effect of myosin inhibitor BDM on skeletal muscle contractile function].
    Yu ZB; Gao F
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 Nov; 21(4):449-52. PubMed ID: 21180172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excitation-contraction uncoupling in the rat diaphragm by 2,3-butanedione monoxime.
    Røed A
    Eur J Pharmacol; 1993 Sep; 241(2-3):229-36. PubMed ID: 8243557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2,3-Butanedione monoxime modifies the glycine-gated chloride current of acutely isolated murine hypothalamic neurons.
    Ye JH; McArdle JJ
    Brain Res; 1996 Sep; 735(1):20-9. PubMed ID: 8905165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-Aminoethoxydiphenyl borate modulates kinetics of intracellular Ca(2+) signals mediated by inositol 1,4,5-trisphosphate-sensitive Ca(2+) stores in single pancreatic acinar cells of mouse.
    Wu J; Kamimura N; Takeo T; Suga S; Wakui M; Maruyama T; Mikoshiba K
    Mol Pharmacol; 2000 Dec; 58(6):1368-74. PubMed ID: 11093775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of anti-myosin drugs on anaphase chromosome movement and cytokinesis in crane-fly primary spermatocytes.
    Silverman-Gavrila RV; Forer A
    Cell Motil Cytoskeleton; 2001 Dec; 50(4):180-97. PubMed ID: 11807939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paralysis of skeletal muscle by butanedione monoxime, a chemical phosphatase.
    Fryer MW; Gage PW; Neering IR; Dulhunty AF; Lamb GD
    Pflugers Arch; 1988 Jan; 411(1):76-9. PubMed ID: 2832824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excitatory amino acid induced currents of isolated murine hypothalamic neurons and their suppression by 2,3-butanedione monoxime.
    Ye JH; McArdle JJ
    Neuropharmacology; 1995 Oct; 34(10):1259-72. PubMed ID: 8570023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the myosin inhibitor 2,3-butanedione monoxime (BDM) on cell shape, locomotion and fluid pinocytosis in human polymorphonuclear leucocytes.
    Urwyler N; Eggli P; Keller HU
    Cell Biol Int; 2000; 24(12):863-70. PubMed ID: 11114235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of 2,3-butanedione monoxime on contraction of frog skeletal muscles: an X-ray diffraction study.
    Yagi N; Takemori S; Watanabe M; Horiuti K; Amemiya Y
    J Muscle Res Cell Motil; 1992 Apr; 13(2):153-60. PubMed ID: 1534565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of protein kinase A partially reverses the effects of 2,3-butanedione monoxime on the transient outward K+ current of rat ventricular myocytes.
    Xiao YF; McArdle JJ
    Life Sci; 1995; 57(4):335-43. PubMed ID: 7603306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increase of atrial ANP release by 2,3-butanedione monoxime in beating rabbit atria.
    Jin JY; Li D; Wen JF; Cho KW
    Regul Pept; 2009 Nov; 158(1-3):91-6. PubMed ID: 19523992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle cross-bridges bound to actin are disordered in the presence of 2,3-butanedione monoxime.
    Zhao L; Naber N; Cooke R
    Biophys J; 1995 May; 68(5):1980-90. PubMed ID: 7612840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2,3-butanedione monoxime blockade of Ca2+ currents in adult rat sympathetic neurons does not involve 'chemical phosphatase' activity.
    Zhu Y; Ikeda SR
    Neurosci Lett; 1993 May; 155(1):24-8. PubMed ID: 8395671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2,3-butanedione monoxime (BDM), a potent inhibitor of actin-myosin interaction, induces ion and fluid transport in MDCK monolayers.
    Castillo AM; Reyes JL; Sánchez E; Mondragón R; Meza I
    J Muscle Res Cell Motil; 2002; 23(3):223-34. PubMed ID: 12500902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of 2,3-butanedione 2-monoxime (BDM) on ventricular trabeculae from the avian heart.
    Brotto MA; Fogaça RT; Creazzo TL; Godt RE; Nosek TM
    J Muscle Res Cell Motil; 1995 Feb; 16(1):1-10. PubMed ID: 7751400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 2,3-Butanedione monoxime suppresses primarily total calcium handling in canine heart.
    Maesako M; Araki J; Lee S; Doi Y; Imaoka T; Iribe G; Mohri S; Hirakawa M; Harada M; Suga H
    Jpn J Physiol; 2000 Oct; 50(5):543-51. PubMed ID: 11120921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.